Autolus Limited
Clinical trials sponsored by Autolus Limited, explained in plain language.
Clinical-stage biopharmaceutical company developing CAR-T cell therapies.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Engineered immune cells take on lupus in first human test
Disease control OngoingThis early-phase trial is testing a one-time treatment called obecabtagene autoleucel (obe-cel) for people with severe lupus that hasn't improved with standard treatments. Obe-cel is made by taking a patient's own immune cells, engineering them to target and attack faulty B cells…
Phase: PHASE1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Engineered immune cells take on tough leukemia in new trial
Disease control OngoingThis study tests a treatment called AUTO1, a type of CAR T cell therapy, in 153 adults whose B cell acute lymphoblastic leukemia has returned or not responded to standard treatments. The therapy involves taking a patient's own immune cells, engineering them to recognize and attac…
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC